Marshall Investment Management Acquires 6,457 Amgen Shares

The investment firm adds to its stake in the biotech giant during the third quarter.

Mar. 17, 2026 at 12:24pm

Got story updates? Submit your updates here. ›

Marshall Investment Management LLC acquired a new stake of 6,457 shares in Amgen Inc. (NASDAQ:AMGN) during the third quarter, according to the firm's latest 13F filing with the Securities and Exchange Commission. The shares were valued at approximately $1.822 million.

Why it matters

Amgen is a major player in the biotechnology industry, developing and manufacturing biologic medicines for serious illnesses. This investment by Marshall Investment Management suggests the firm sees growth potential in Amgen's business and stock.

The details

The 13F filing shows that Marshall Investment Management acquired the new stake in Amgen during the third quarter of the year. Amgen's stock has seen significant movement in recent months, with the share price rising from around $325 to over $375 as the company continues to advance its drug pipeline and commercial portfolio.

  • Marshall Investment Management acquired the 6,457 Amgen shares in the third quarter of 2026.

The players

Marshall Investment Management LLC

An investment management firm that acquired a new stake in Amgen Inc. during the third quarter.

Amgen Inc.

A global biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics to address serious illnesses.

Got photos? Submit your photos here. ›

The takeaway

This investment by Marshall Investment Management highlights the continued interest in Amgen's business and the potential for growth in the biotech sector, even as the company faces competition and pricing pressures in its key therapeutic areas.